August 26, 2020
Interim report April-June 2020
Media
August 25, 2020
CARISMA Therapeutics Enters Into Scientific Research and Licensing Agreement With NYU Langone Health, Gains Exclusive Rights to Vpx Lentiviral Vector
August 25, 2020
Vicore Pharma restarts mechanistic study with VP01 in systemic sclerosis
August 21, 2020
Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2020 Results Presentation and Webcast – correction
August 20, 2020
Targovax ASA: second quarter and first half 2020 results
August 14, 2020
Vicore Pharma publishes a prospectus for admission to trading of shares on Nasdaq Stockholm in connection with a directed share issue
August 12, 2020
Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August
August 11, 2020
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results And Business Update
August 11, 2020
Aprea Therapeutics Reports Second Quarter 2020 Financial Results and Provides Update on Business Operations
August 10, 2020
Orexo receives paragraph IV Notice Letter for ZUBSOLV® in the US
